Keith Wilson

Title: Keith Wilson: Innovator in Cancer Treatment

Introduction

Keith Wilson is a notable inventor based in Mountainside, NJ (US). He has made significant contributions to the field of cancer treatment, particularly in the methods of treating acute myeloid leukemia and multiple myeloma. His innovative approach utilizes natural killer cells to combat these aggressive forms of cancer.

Latest Patents

Keith Wilson holds 1 patent for his groundbreaking work titled "Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells." This patent outlines methods for treating acute myeloid leukemia (AML) and multiple myeloma (MM) by administering an effective amount of a cell population comprising natural killer cells. The process involves a three-stage method that begins with culturing hematopoietic stem or progenitor cells in media containing stem cell mobilizing factors. This innovative technique aims to produce natural killer cells from various sources, including placental perfusate and umbilical cord blood, to suppress the proliferation of AML cells.

Career Highlights

Keith Wilson is associated with Celularity Inc., a company focused on advancing cell-based therapies. His work at Celularity has positioned him as a key player in the development of novel cancer treatments. His research and inventions have the potential to significantly impact the lives of patients suffering from these challenging diseases.

Collaborations

Throughout his career, Keith has collaborated with esteemed colleagues such as Steven Alan Fischkoff and Uri Herzberg. These partnerships have fostered an environment of innovation and have contributed to the advancement of cancer treatment methodologies.

Conclusion

In summary, Keith Wilson is a pioneering inventor whose work in cancer treatment through natural killer cells represents a significant advancement in medical science. His contributions continue to inspire and pave the way for future innovations in the field.